Back to Journals » Drug Design, Development and Therapy » Volume 10

Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial

Total article views   HTML views PDF downloads Totals
9,489 Dovepress* 8,548+ 1,350 9,898
PubMed Central* 941 350 1,291
Totals 9,489 1,700 11,189
*Since 25 July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed and Google Scholar